Torbay Pharma’s Post

🌐 KanBo for Senior Director Commercial Relations 🔍 Challenge: Elevate collaboration and strategic partnership management in the fast-paced Pharmaceuticals industry. 🌟 KanBo Solutions: Space: Create dedicated workspaces for seamless information exchange. Card: Utilize cards for managing responsibilities, negotiations, and team performance. Card Activity Stream: Monitor real-time activities for transparency and performance tracking. KanBo Search: Quickly locate critical information for informed decision-making. Notifications: Keep stakeholders updated with prompt and relevant alerts. Reminder: Set personalized reminders for task and deadline management. 🌈 Outcomes: Enhanced Collaboration Systematic Direction Strategic Planning Improved Coordination Transparency Across Workflows Increased Team Unity Efficient Communication Swift Response to Changes Opportunity Harnessing Competitive Edge 🔮 Expectations: Improved Time and Resource Management Enhanced Stakeholder Satisfaction Increased Productivity Sustained Growth Continuous Improvement 💼 In conclusion, KanBo empowers Senior Directors of Commercial Relations, fostering strategic collaboration and robust partnerships in the dynamic Pharmaceuticals sector! #KanBo #CommercialRelations #Pharmaceuticals #Collaboration #StrategicPartnerships #Efficiency #DecisionMaking #ContinuousImprovement https://lnkd.in/dzyvJ2tD

🌟 Focus on Irish Pharma: the key insights… The Irish biopharma sector is a cornerstone of our economic success and is set for a tremendous growth spurt. Minister for Enterprise, Trade and Employment Peter Burke underscores the sector’s critical role for Ireland. ☘️ Key Insights: ✅ Up to 26,000 Jobs to be Created Over the Next Five Years ✅ Pharmaceutical exports hit nearly €9bn last January ✅ Over 50,000 people currently employed ✅ Over 85 multinational and indigenous companies driving Irish expansion At Oleson, we are dedicated to supporting this vibrant as it continues to expand. Our goal is to ensure continuity and stability for our clients, even in times of skill shortages. With our deep industry knowledge and specialist resource teams, we are committed to driving the success and growth of the life sciences sector in Ireland. 🚀 #LifeSciences #PharmaBoom #TalentAcquisition #Oleson

Pharma sales professionals, are you looking for ways to improve your sales strategy? Here are few tips to consider: 1. Continuous training: Keep your sales team up-to-date with ongoing training programs that cover new products, industry regulations, and sales techniques. This investment will ensure your team is well-informed, confident, and ready to close deals. 2. Strategic pricing: Develop competitive pricing strategies that offer value to healthcare professionals while remaining financially attractive for institutions. This approach will help you stand out in a crowded market and build long-lasting relationships with your clients. Invest in your sales team and pricing strategy to drive success in pharma sales. #Kareersity #Arlynlife #Humankind #RJBA #pharmaceuticalindustry #pharmapricing #learninganddevelopment

𝗜𝗺𝗮𝗴𝗶𝗻𝗲 𝗮 𝘀𝗶𝗻𝗴𝗹𝗲 𝗽𝗵𝗮𝗿𝗺𝗮 𝗽𝗿𝗼𝗷𝗲𝗰𝘁 𝗰𝗿𝗲𝗮𝘁𝗶𝗻𝗴 𝟭,𝟬𝟬𝟬 𝗷𝗼𝗯𝘀... 𝗧𝗵𝗮𝘁'𝘀 𝘁𝗵𝗲 𝗲𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗿𝗲𝗮𝗹𝗶𝘁𝘆 𝗘𝗹𝗶 𝗟𝗶𝗹𝗹𝘆 𝗶𝘀 𝗯𝗿𝗶𝗻𝗴𝗶𝗻𝗴 𝘁𝗼 𝗚𝗲𝗿𝗺𝗮𝗻𝘆 𝘄𝗶𝘁𝗵 𝗮 𝗘𝗨𝗥 𝟮.𝟯𝟬 𝗯𝗶𝗹𝗹𝗶𝗼𝗻 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁! 𝗧𝗵𝗲 𝗱𝗲𝘁𝗮𝗶𝗹𝘀👇 Eli Lilly, the renowned pharmaceutical corporation headquartered in the United States, has announced a transformative initiative to enhance healthcare production capabilities in western Germany. This initiative is seen as a strong endorsement of Germany as a prime location for pharmaceutical and industrial activities. Eli Lilly is allocating an investment of approximately 2.3 billion euros ($2.50 billion) for the establishment of an avant-garde production facility. This investment represents a pivotal effort to strengthen its presence within the European market. The selected site in Alzey, Germany, marks Eli Lilly's inaugural large-scale production complex within the country and is projected to create in excess of 1,000 employment opportunities. This initiative underscores Eli Lilly's dedication to stimulating economic development in the region and advancing the pharmaceutical industry's infrastructure. The forthcoming facility is strategically designed to augment Eli Lilly's manufacturing capabilities for injectable products and devices, including Mounjaro, a medication hyped for weight loss and diabetes treatment, catering to the rising demand for injectable medications in the realm of weight management. 💉💊 By incorporating this facility into its operations, Eli Lilly further solidifies its stature as a leading entity in global healthcare, with the German site becoming the sixth manufacturing location in Europe under the company's banner. Additionally, this endeavor is expected to significantly benefit local subcontractors and suppliers by promoting a synergistic environment conducive to shared advancement. Eli Lilly's strategic investment is reflective of an acknowledgment towards the necessity of resilient supply chains, particularly in the aftermath of the global pandemic. The German government receives commendation for creating a conducive atmosphere for investment by major industry stakeholders like Eli Lilly. Despite facing challenges such as fluctuations in energy prices, this collaborative effort exemplifies Germany's position as a robust and appealing locale for manufacturing operations. #elililly #pharmaceuticalindustry #marketentry #germany

Pharma reshoring presents a strategic opportunity to enhance operations and outcomes by creating secure, reliable, high-quality manufacturing processes closer to home. Gaelic Labs’ reshoring strategy enhances its USP of being faster, better and more competitive.   Brian Morrissey is General Manager at Gaelic Laboratories. Here are his top 5 reasons for making the most of the company's approach to reshoring pharma manufacturing and production services...   1.      Medicinal safety and quality control As supply chains grow more complex, there are more vulnerabilities for criminals to exploit. That’s why efforts to eliminate fraudulent activity are largely focused on increasing visibility across the supply chain. Reshoring can help customers better understand and control supply chains to prevent illicit activities affecting their products. It can also protect product quality and brand reputation.   2.      Agile production Transportation delays, such as those witnessed recently in the Red Sea and Suez Canal, have led to longer lead times, shortages and higher costs for imported generic medicines. EU production can allow for quicker turnaround times and more agile supply chains that meet rises and falls in demand. It can also support a “just in time” model, where goods are only received at the exact time they are needed, cutting waste and inventory costs. 3.      Supply chain resilience Security is a large concern for pharma companies in today’s uncertain geopolitical landscape, and at a time of increasing trade disputes and natural disasters. A less fragmented supplier base can limit the impact of these insecurities and reduce exposure to risk across the board. This, in turn, supports national security by ensuring uninterrupted access to vital drugs such as Beta-Lactams.   4.      Economic growth Beyond ensuring a stable drug supply, reshoring pharmaceutical manufacturing can stimulate economic growth. It creates job opportunities, fosters innovation, and supports local businesses, thus contributing to the overall prosperity of the local economy. Domestic reshoring can also create greater potential for collaboration between manufacturers, researchers and academic institutions on European soil, helping to spur innovation, accelerate drug development and advance medical science.   5.      Cutting carbon emissions Carbon reduction and reshoring go hand in hand. Transporting materials and products thousands of miles before they reach the end consumer creates large carbon footprints. EU production can help companies achieve their environmental goals by reducing emissions within their supply chain.   Find out more at https://gaeliclabs.com   #betalactams #penicillins #antibiotics #medicine #cdmo #pharmaceuticals #labtesting #pharmaceuticalmanufacturing Brian Morrissey Hamed Al-Grou Tristan Jervis Sarah H.  

🌟 Introducing Our "10 Reasons Why" Series! 🌟 In the ever-evolving world of pharmacy logistics, choosing the right partner can make all the difference. But with so many options and factors to consider, how do you know you're making the best choice for your pharmacy or healthcare facility? 🤔💡 That's where we come in. At Ontime Globe Kyarrier Pvt Ltd, we're not just another logistics provider; we're your dedicated partner for developing and implementing logistics solutions for the lifescience industry. 🚚💊 Starting tomorrow, we're excited to launch our "10 Reasons Why" series, right here on LinkedIn. Over the next ten days, we'll share the top ten reasons why we stand out from the crowd, and why partnering with us means you're choosing excellence in every aspect of pharmacy logistics. From our groundbreaking direct transport method to our unwavering commitment to safety and compliance, we're here to make a difference. Stay tuned, and let's explore how we can elevate your logistics from good to great, one reason at a time. 🌈✨ RRajesh M Ontime Globe Kyarrier Pvt Ltd #PharmacyLogistics #10ReasonsWhy #Innovation #OntimeGlobeKyarrier #awareness #science #transport #logistics #pharmaceuticals #biopharmaceuticals #biologicalsamples

� Exciting Career Transition into Pharmaceutical Sales! �� After a fulfilling career in education, I am thrilled to share that I am transitioning into the pharmaceutical sales industry! �� With extensive experience as an Assistant Principal, Science Teacher, and Assistant Athletic Director, I have honed my skills in relationship-building, strategic planning, and achieving excellence. These skills are directly transferable to pharmaceutical sales, where understanding client needs, strategic outreach, and effective communication are key. Why pharmaceutical sales? The opportunity to influence patient outcomes and contribute to healthcare advancements is incredibly motivating. I am eager to leverage my background in education and sales to excel in this field—driving success by building strong relationships with healthcare professionals and delivering impactful solutions. As I start this new chapter, I am keen to connect with industry professionals and explore opportunities in pharmaceutical sales. Any leads, advice, or opportunities in this exciting field would be greatly appreciated. #CareerTransition #PharmaceuticalSales #NewBeginnings #Sales #Healthcare #ProfessionalGrowth

To watch the full video, Tap the link given below or Link in comment! https://bit.ly/4aFHLIF Join Mr. Prashant Bohra for valuable insights on kickstarting your pharma career. In this engaging session, Mr. Prashant Bohra delves into crucial aspects including understanding and learning 📚, networking 🤝, socializing 🎉, and honing communication skills 💬. Discover practical advice and strategies to propel your career forward. Don't miss this opportunity to gain valuable knowledge and set yourself up for success in the pharmaceutical industry. #kareersity #kareersityguidance #pharmaInsights #careerguidance #industryperspective #pharmajeeto #guidance #careeradvice #pharmaindustry 

We’re creating tomorrow's pharma industry leaders, today! With our ongoing medical representative class at the Dumdum branch, the Endeavour Pharma Institute is shaping ambitious minds for successful careers in pharma. Want to be a part of the change? Enroll now! . . . . . . . #PharmaLeaders #MedicalRepresentatives #EndeavourPharmaInstitute #PharmaEducation #CareerDevelopment #AmbitiousMinds #PharmaTraining #FutureLeaders #SuccessInPharma #MedicalSales #PharmaIndustry #DumdumBranch #EnrollNow #AmbitiousCareers #PharmaTrainingProgram

Companies in the pharmaceutical sector are ramping up their search for executive talent, Rica Bhattacharyya and Viswanath Pilla report for The Economic Times. The active pharmaceutical ingredient (API) segment, in particular, is looking for chief executives, chief operating officers, and chief legal officers, the report says. This includes companies such as Cohance Lifesciences, Sekhmet Pharmaventures, Aurobindo Pharma, and Nirma, which recently acquired Glenmark Life Sciences. India is emerging as a destination for API manufacturing and the sector is attracting more investments, says Rahul Shah, co-founder and Director at WalkWater Talent Advisors. The pay package for these roles is anywhere between ₹1.75 crore to ₹2.50 crore, he adds. The candidates are required to have a deep understanding of the global market, regulatory requirements, and must also be able drive company growth, the report adds. Source: The Economic Times - https://lnkd.in/d4Ng_KKj ✍: Preethi Ramamoorthy 📸: Getty Images #Pharmaceutical #PharmaIndustry #CXOTalent #CXOHiring